Minodronic Acid Hydrate

米诺膦酸

Report date: 2026/01/05 10:14:14
NME

Base Information

Drug NameMinodronic Acid Hydrate
Drug Alias Nameacide minodronique米诺膦酸水合物MinodronateMinodronacidum minodronicum +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFarnesyl diphosphate synthase inhibitors
TargetsFarnesyl diphosphate synthase
Therapy Area/IndicationsOsteoporosis, PostmenopausalOsteoporosisBone Diseases
Global Approved IndicationsOsteoporosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2019/01/21
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesOno Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma IncHefei Industrial Pharmaceutical Co LtdShandong Chuangxin Pharmacy R&D Co Ltd +[7] 
Inactive CompaniesOno Pharmaceutical Co LtdOno Pharma Usa IncAnhui Xinxing Pharmacy Development Co Ltd
Active IndicationsOsteoporosis, PostmenopausalOsteoporosis
Inactive IndicationsBone Diseases

Other Information

ATC CodeM05
Related LinksKEGG